abm (applied biological materials)

abm is a global biotechnology company headquartered in Canada, with offices in France, offering a portfolio of over one million research products supporting molecular biology, cell biology, and gene editing. The company specialises in cellular and genetic materials, including extensive collections of primary, immortalised, tumour, and CRISPR‑engineered cell lines, alongside PCR and qPCR reagents. abm also provides advanced gene delivery technologies, including lentiviral, AAV, and adenoviral vector systems, supported by integrated services such as gene synthesis, cloning, and viral packaging. In addition, the company is expanding its capabilities in 3D cell culture and organoid solutions, enabling more physiologically relevant models for disease research and drug discovery, and positioning abm as a flexible, end‑to‑end partner for life science research

Contact our abm specialists to learn more about the portfolio.